Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2025 ,inter alia, to consider and approve 1. To Update regarding the current business operations of the Company. 2. Any other matter with permission of the Chair.

pdf

Ishita Drugs & Industries Ltd.

30 May 2025

84.00

2.28%

Company Update

Ishita Drugs & Industries Ltd - 524400 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation for Appointment of Secretarial Auditor.

pdf

Ishita Drugs & Industries Ltd.

30 May 2025

84.00

2.28%

Result

Ishita Drugs & Industries Ltd - 524400 - Outcome Of Board Meeting Held On 30Th May, …

BSE India

Audited Financial Results for the quarter and year ended on 31st March, 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	4.72	4.20	4.60	12.4%	2.6%
Operating Profit Qtr	0.29	0.30	0.29	-3.3%	0.0%
Net Profit Qtr	0.29	0.24	0.28	20.8%	3.6%
Earning Per Share Adjusted latest Qtr	0.96	0.80	0.94	20.0%	2.1%

* Standalone data

Detailed Results

Ishita Drugs & Industries Ltd.

30 May 2025

84.00

2.28%

Board Meeting

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Outcome of Board Meeting held on 30th May, 2025

pdf

Ishita Drugs & Industries Ltd.

23 May 2025

84.00

2.28%

Board Meeting

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Intimation for Intimation Of Board Meeting …

BSE India

Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March, 2025 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. To consider and approve the Directors' Report with the Annexure, Corporate Governance Report, Management Discussion and Analysis Report and Notice for convening the 32nd Annual General Meeting of the Company. 3. To consider the appointment of M/s Meenu Maheshwari & Associates, Practicing Company Secretary as the Secretarial Auditor of the Company for the year 2025-26. 4. To consider the re-appointment of Mr. Arvind Sapkal [DIN: 08607096] for the further term of Five years as an Independent Non-Executive Director of the Company. 5. To consider the re-appointment of Internal Auditors of the Company for the year 2025-26. 6. To take on record Disclosure of Interest of Directors. 7. Any other matter with permission of the Chair.

pdf